Shock Wave Lithotripsy for Renal and Ureteric Stones

Slides:

Advertisements

Similar presentations

Volume 84, Issue 4, Pages (October 2014)

Advertisements

Medical Management for BPH: The Role of Combination Therapy

Pascal Rischmann European Urology Supplements

Recurrent Urinary Tract Infections: Uro-Vaxom®, a New Alternative

Volume 199, Issue 4, Pages e117-e118 (April 2018)

Recurrent Urinary Tract Infections: Uro-Vaxom®, a New Alternative

Management of Acute and Chronic Retention in Men

Olivier Traxer European Urology Supplements

Volume 72, Issue 5, Pages (November 2017)

The Role of Lymphadenectomy in Radical Cystectomy

Volume 60, Issue 2, Pages (August 2011)

Bladder Cancer: Management and Future Directions

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Shock Wave Lithotripsy for Renal and Ureteric Stones

Volume 50, Issue 5, Pages (November 2006)

Martin C. Michel European Urology Supplements

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Bladder Cancer: A Major Public Health Issue

What is New in Bladder Cancer Diagnosis and Management?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Back to the Future: Introduction and Conclusions

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Volume 52, Issue 6, Pages (December 2007)

Volume 52, Issue 3, Pages (September 2007)

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Global Burden of Urologic Cancers, 1990–2013

An Update of Current Practice in Hypospadias Surgery

Sperm Cells for Artificial Reproduction and Germ Cell Transplantation

Richard C. Harkaway European Urology Supplements

Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma Sergio Bracarda, Alain Ravaud, Marino.

Tim Schneider European Urology Supplements

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

The Importance of Testosterone Control in Prostate Cancer

Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis

Laparoscopic Cryoablation of Small Renal Masses: Technique and Results after 6-Year Experience Andrea Cestari, Giorgio Guazzoni, Nicolò Maria Buffi,

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

Long-Term Hormonal Therapy: Who Would Benefit?

Sergio Bracarda European Urology Supplements

Pharmacotherapy in Stress and Mixed Incontinence

Christian Stief European Urology Supplements

New Trends in Managing the Prostate Cancer Patient

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Who Forms Stones and Why?

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

Retrocaval Ureter—Magnetic Resonance Appearances

The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior John Dean

Improving Flexibility and Quality of Life for Your Patients: A Must?

Volume 4, Issue 5, Pages 2-3 (October 2006)

Profile of Silodosin European Urology Supplements

Stone Disease European Urology Supplements

New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men

Improving Stone Clearance After Extracorporeal Shock Wave Lithotripsy in Urolithiasis Patients by a Special Terpene Combination (Rowatinex®): Results.

Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Treatment Options in Prostate Cancer Once Primary Therapy Fails

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Radiofrequency Ablation of Metastases from Renal Cell Carcinoma: Technique, Complications, and Midterm Outcome Christian Kloeters, Ann-Kathrin Mager,

Joaquim Bellmunt European Urology Supplements

Classification of Mixed Incontinence

The Impact of Premature Ejaculation on Partners and Relationships

Diagnosis and Management of Cryptorchidism

Jan Roigas European Urology Supplements

Volume 51, Issue 5, Pages (May 2007)

Michael Marberger European Urology Supplements

Appropriate Castration with Luteinising Hormone Releasing Hormone (LHRH) Agonists: What is the Optimal Level of Testosterone? B. Tombal European Urology.

Presentation transcript:

Shock Wave Lithotripsy for Renal and Ureteric Stones Christian Bach, Noor Buchholz European Urology Supplements Volume 10, Issue 5, Pages 423-432 (October 2011) DOI: 10.1016/j.eursup.2011.07.004 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Optimizing shock wave lithotripsy. BMI=body mass index; KUB=kidneys, ureters, and bladder; MET=medical expulsive therapy; NCCT=non–contrast-enhanced computed tomography; PID=percussion, inversion, and diuresis; UT=upper tract; UTI=urinary tract infection. European Urology Supplements 2011 10, 423-432DOI: (10.1016/j.eursup.2011.07.004) Copyright © 2011 European Association of Urology Terms and Conditions